Cell therapy and gene therapy are forms of medical treatment under the regenerative medicine umbrella that involve the introduction of live cells or genetic material into the body to treat or cure a disease. 

Cell therapy is where a cell—either autologous (using cells from the patients themselves) or allogeneic (using cells from other individuals)—is introduced into a patient's body to repair or replace damaged cells. Gene therapy is where a functional copy of a disease-causing gene is inserted into a patient's cells to replace a faulty version of the gene. Both therapies hold promise for treating a range of conditions, including genetic disorders, cancer, and immune and cardiovascular diseases. Cell and gene therapies intend to identify and address the root cause of diseases, as opposed to currently prevalent treatment methods (e.g. drugs and surgeries) that often only address symptoms.

*Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.